Source: International Congress 2015 – New models for treating airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Remi Villenave (Boston, United States of America), Remi Villenave, Kambez Benam, Carolina Lucchesi, Antonio Varone, Thomas Ferrante, Cedric Hubeau, Hyun-Hee Lee, Michael Salmon, Steve Alves, James Weaver, Geraldine Hamilton, Tony Bahinski, Donald Ingber. Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip. Eur Respir J 2015; 46: Suppl. 59, 3567

Member's Comments

No comment yet.

Related content which might interest you: Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Crosstalk between lung fibroblasts and T-lymphocytes: Implications for anti-viral responses in chronic lung disease Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Multi-analyte profiling of inflammatory markers in COPD sputum Source: International Congress 2014 – Translational studies in COPD Year: 2014 CD39 deficiency results in increased inflammation in an animal model of pulmonary fibrosis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 B-cell infiltration varies among patients with interstitial lung diseases Source: International Congress 2016 – ILD pathogenesis Year: 2016 Lung inflammation: The role of alveolar macrophages Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Determinants of inflammatory and functional toxicity of silver nanospheres in rat lung Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 A comparative study of pulmonary host defense in murine obesity models: Important insights into neutrophil function Source: International Congress 2016 – Translational research in respiratory infections Year: 2016 A potential role for endothelial adhesion molecules and cytokines in chemotherapy-induced lung fibrosis Source: International Congress 2014 – Cell biology 2014 Year: 2014 Modulation of neutrophil functionalities by indacaterol and their relevance for chronic lung diseases Source: International Congress 2014 – Translational studies in COPD Year: 2014 A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Mouse pathway biology models: Investigating the biology of alternaria alternata induced lung inflammation in the mouse - Role of ILC2 and Th2 cytokines Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Acute markers of neutrophilic lung infiltration in the non-human primate LPS model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014